Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study

Gastroenterology

Volumn 133, Issue 2, 2007, Pages 423-432

  Turner, Dan ^a   Otley, Anthony R ^b   Mack, David ^c   Hyams, Jeffrey ^d   de Bruijne, J ^a   Uusoue, Krista ^a   Walters, Thomas D ^a   Zachos, Mary ^a   Mamula, Petar ^e   Beaton, Dorcas E ^f   Steinhart, A Hillary ^g   Griffiths, Anne M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; MESALAZINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COLONOSCOPY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ACTIVITY; EFFECT SIZE; ENDOSCOPY; EVALUATION RESEARCH; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MALE; MEDICAL EXPERT; MULTICENTER STUDY; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; SCORING SYSTEM; TEST RETEST RELIABILITY; ULCERATIVE COLITIS; VALIDATION STUDY; CANADA; COMPARATIVE STUDY; DELPHI STUDY; EVALUATION; HOSPITALIZATION; OBSERVER VARIATION; PREDICTION AND FORECASTING; PRESCHOOL CHILD; QUESTIONNAIRE; REPRODUCIBILITY; ROC CURVE; TIME; UNITED STATES;

ADOLESCENT; CANADA; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; COLONOSCOPY; DELPHI TECHNIQUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; UNITED STATES;

EID: 34547563048     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.05.029     Document Type: Article

References (56)

1. Griffiths A.M. Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol 18 (2004) 509-523
2. Sands B.E. Biological therapies for ulcerative colitis. Acta Gastroenterol Belg 64 (2001) 205-209
3. Best W.R., Becktel J.M., Singleton J.W., and Kern Jr. F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70 (1976) 439-444
4. Seo M., Okada M., Yao T., Ueki M., Arima S., and Okumura M. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 87 (1992) 971-976
5. Truelove S.C., and Witts L.J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J (1955) 1041-1048
6. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 298 (1989) 82-86
7. Schroeder K.W., Tremaine W.J., and Ilstrup D.M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 317 (1987) 1625-1629
8. Lichtiger S., and Present D.H. Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet 336 (1990) 16-19
9. Powell-Tuck J., Bown R.L., and Lennard-Jones J.E. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 13 (1978) 833-837
10. Walmsley R.S., Ayres R.C., Pounder R.E., and Allan R.N. A simple clinical colitis activity index. Gut 43 (1998) 29-32
11. Azzolini F., Pagnini C., Camellini L., Scarcelli A., Merighi A., Primerano A.M., Bertani A., Antonioli A., Manenti F., and Rigo G.P. Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis. Dig Dis Sci 50 (2005) 246-251
12. D'Haens G., Sandborn W.J., Feagan B.G., Geboes K., Hanauer S.B., Irvine E.J., Lemann M., Marteau P., Rutgeerts P., Scholmerich J., and Sutherland L.R. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 132 (2007) 763-786
13. Kirshner B., and Guyatt G. A methodological framework for assessing health indices. J Chronic Dis 38 (1985) 27-36
14. Schachter H., and Kirsner J.B. Definitions of inflammatory bowel disease of unknown etiology. Gastroenterology 68 (1975) 591-600
15. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., Caprilli R., Colombel J.F., Gasche C., Geboes K., Jewell D.P., Karban A., Loftus Jr. E.V., Pena A.S., Riddell R.H., Sachar D.B., Schreiber S., Steinhart A.H., Targan S.R., Vermeire S., and Warren B.F. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19 Suppl A (2005) 5-36
16. Marx R.G., Bombardier C., Hogg-Johnson S., and Wright J.G. Clinimetric and psychometric strategies for development of a health measurement scale. J Clin Epidemiol 52 (1999) 105-111
17. Marx R.G., Bombardier C., Hogg-Johnson S., and Wright J.G. How should importance and severity ratings be combined for item reduction in the development of health status instruments?. J Clin Epidemiol 52 (1999) 193-197
18. Wright J.G., and Feinstein A.R. A comparative contrast of clinimetric and psychometric methods for constructing indexes and rating scales. J Clin Epidemiol 45 (1992) 1201-1218
19. Beattie R.M., Nicholls S.W., Domizio P., Williams C.B., and Walker-Smith J.A. Endoscopic assessment of the colonic response to corticosteroids in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 22 (1996) 373-379
20. Mary J.Y., Modigliani R., and Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Gut 30 (1989) 983-989
21. Gomes P., du Boulay C., Smith C.L., and Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 27 (1986) 92-95
22. Guyatt G.H., Deyo R.A., Charlson M., Levine M.N., and Mitchell A. Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol 42 (1989) 403-408
23. Kundhal P.S., Critch J.N., Zachos M., Otley A.R., Stephens D., and Griffiths A.M. Pediatric Crohn's Disease Activity Index: responsive to short-term change. J Pediatr Gastroenterol Nutr 36 (2003) 83-89
24. Schunemann H.J., Puhan M., Goldstein R., Jaeschke R., and Guyatt G.H. Measurement properties and interpretability of the Chronic Respiratory Disease Questionnaire (CRQ). COPD 2 (2005) 81-89
25. Guyatt G.H., Norman G.R., Juniper E.F., and Griffith L.E. A critical look at transition ratings. J Clin Epidemiol 55 (2002) 900-908
26. Hays R.D., and Woolley J.M. The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?. Pharmacoeconomics 18 (2000) 419-423
27. Beaton D.E., Boers M., and Wells G.A. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol 14 (2002) 109-114
28. Shrout P., and Fleiss J. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86 (1979) 420-428
29. Deyo R.A., and Centor R.M. Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. J Chronic Dis 39 (1986) 897-906
30. Liang M.H., Fossel A.H., and Larson M.G. Comparisons of five health status instruments for orthopedic evaluation. Med Care 28 (1990) 632-642
31. Stratford P.W., Binkley F.M., and Riddle D.L. Health status measures: strategies and analytic methods for assessing change scores. Phys Ther 76 (1996) 1109-1123
32. Guyatt G., Walter S., and Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 40 (1987) 171-178
33. Babyak M.A. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 66 (2004) 411-421
34. Streiner D.L. The case of the missing data: methods of dealing with dropouts and other research vagaries. Can J Psychiatry 47 (2002) 68-75
35. Lindgren S.C., Flood L.M., Kilander A.F., Lofberg R., Persson T.B., and Sjodahl R.I. Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol 10 (1998) 831-835
36. Travis S.P., Farrant J.M., Ricketts C., Nolan D.J., Mortensen N.M., Kettlewell M.G., and Jewell D.P. Predicting outcome in severe ulcerative colitis. Gut 38 (1996) 905-910
37. Jakobovits S.L., and Travis S.P. Management of acute severe colitis. Br Med Bull 75-76 (2006) 131-144
38. Behrman R., Kliegman R., and Jenson H. Nelson textbook of pediatrics (2006), W. B. Saunders Company, Philadelphia
39. Hanauer S., Schwartz J., Robinson M., Roufail W., Arora S., Cello J., Safdi M., and Pentasa Study Group. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Am J Gastroenterol 88 (1993) 1188-1197
40. Hyams J.S., Ferry G.D., Mandel F.S., Gryboski J.D., Kibort P.M., Kirschner B.S., Griffiths A.M., Katz A.J., Grand R.J., Boyle J.T., et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 12 (1991) 439-447
41. Irvine E. Assessing outcomes in clinical trials. In: Satsangi J.S.L. (Ed). Inflammatory bowel disease (2003), Churchill Livingstone, Philadelphia 319-333
42. Holmquist L., Ahren C., and Fallstrom S.P. Clinical disease activity and inflammatory activity in the rectum in relation to mucosal inflammation assessed by colonoscopy. A study of children and adolescents with chronic inflammatory bowel disease. Acta Paediatr Scand 79 (1990) 527-534
43. Cellier C., Sahmoud T., Froguel E., Adenis A., Belaiche J., Bretagne J.F., Florent C., Bouvry M., Mary J.Y., Modigliani R., and The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. Gut 35 (1994) 231-235
44. Seo M., Okada M., Maeda K., and Oh K. Correlation between endoscopic severity and the clinical activity index in ulcerative colitis. Am J Gastroenterol 93 (1998) 2124-2129
45. Maunder R.G., and Greenberg G.R. Comparison of a disease activity index and patients' self-reported symptom severity in ulcerative colitis. Inflamm Bowel Dis 10 (2004) 632-636
46. Higgins P.D., Schwartz M., Mapili J., and Zimmermann E.M. Is endoscopy necessary for the measurement of disease activity in ulcerative colitis?. Am J Gastroenterol 100 (2005) 355-361
47. Feinstein A.R. "Clinical Judgment" revisited: the distraction of quantitative models. Ann Intern Med 120 (1994) 799-805
48. Dawes R.M., Faust D., and Meehl P.E. Clinical versus actuarial judgment. Science 243 (1989) 1668-1674
49. Streiner D.L. Clinimetrics vs. psychometrics: an unnecessary distinction. J Clin Epidemiol 56 (2003) 1142-1149
50. Liang M.H. Evaluating measurement responsiveness. J Rheumatol 22 (1995) 1191-1192
51. Stucki G., Liang M.H., Fossel A.H., and Katz J.N. Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis. J Clin Epidemiol 48 (1995) 1369-1378
52. Su C., Lichtenstein G.R., Krok K., Brensinger C.M., and Lewis J.D. A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease. Gastroenterology 126 (2004) 1257-1269
53. Sands B.E., Steinhart A.H., Lewis J.D., Hanauer S.B., Persson T., and Sandborn W.J. Optimal Crohn's Disease Activity Index (CDAI) response criteria is defined by decrease >100 points (abstr). Gastroenterology 124 (2003) A206
54. Norman G.R., Sloan J.A., and Wyrwich K.W. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41 (2003) 582-592
55. In: Higgins J.P.T., and Green S. (Eds). Cochrane handbook for systematic reviews of interventions 4.2.5. The Cochrane library. 3rd ed. (2005), John Wiley & Sons, Ltd, Chichester, UK
56. Werlin S.L., and Grand R.J. Severe colitis in children and adolescents: diagnosis: course and treatment. Gastroenterology 73 (1977) 828-832